Expertise in
1
conditions

Beatriz Castelo

La Paz, MD, ES 
Expertise in
1
conditions
La Paz, MD, ES 

Overview

Beatriz Castelo practices practicing medicine in La Paz, Spain.

Ms. Castelo is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Thyroid Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Dystrophic Epidermolysis Bullosa.

She is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

La Paz, MD 28046, Spain
Other Locations
261st De La Castellana St, El Pardo, MD 28046, Spain
Madrid, MD, Spain
Castellana, MD 28046, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
A Multicenter, Randomized, Phase II Trial Evaluating the Efficacy of Eribulin Monotherapy and Eribulin Plus Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients After Progression on Endocrine Therapy (REVERT)
A Multicenter, Randomized, Phase II Trial Evaluating the Efficacy of Eribulin Monotherapy and Eribulin Plus Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients After Progression on Endocrine Therapy (REVERT)
Enrollment Status: Terminated
Publish Date: August 31, 2021
Intervention Type: Drug
Study Drug: Eribulin
Study Phase: Phase 2
Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Enrollment Status: Completed
Publish Date: May 24, 2019
Intervention Type: Other
Study Phase: Phase 3
Phase IB-II Clinical Trial of Melatonin Oral Gel for the Prevention and Treatment of Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation.
Phase IB-II Clinical Trial of Melatonin Oral Gel for the Prevention and Treatment of Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation.
Enrollment Status: Completed
Publish Date: March 01, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

45 Total Publications

NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.
NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.
Journal: International journal of molecular sciences
Published: January 26, 2026

Frequently Asked Questions about Beatriz Castelo

Is Beatriz Castelo a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Beatriz Castelo is classified as an Advanced expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Beatriz Castelo participate in research or clinical trials?

Yes. Beatriz Castelo has published 45 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Beatriz Castelo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Castelo's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile